Sichuan Kelun Pharmaceutical Co Ltd (002422) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥537.31 Million ≈ $78.62 Million USD) by net assets (CN¥28.62 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sichuan Kelun Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Sichuan Kelun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sichuan Kelun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002422 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bluescope Steel Ltd
AU:BSL
|
0.069x |
|
Pandora A/S
CO:PNDORA
|
0.010x |
|
Solstice Advanced Materials, Inc
NASDAQ:SOLS
|
0.165x |
|
OGE Energy Corporation
NYSE:OGE
|
-0.003x |
|
Autoliv Inc
ST:ALIV-SDB
|
-0.028x |
|
Konfoong Materials International Co Ltd
SHE:300666
|
0.018x |
|
Brinker International Inc
NYSE:EAT
|
0.572x |
|
Rexel S.A
PA:RXL
|
0.147x |
Annual Cash Flow Conversion Efficiency for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. View Sichuan Kelun Pharmaceutical Co Ltd (002422) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥29.29 Billion ≈ $4.29 Billion |
CN¥2.64 Billion ≈ $386.62 Million |
0.090x | -46.32% |
| 2024-12-31 | CN¥26.74 Billion ≈ $3.91 Billion |
CN¥4.49 Billion ≈ $657.45 Million |
0.168x | -27.54% |
| 2023-12-31 | CN¥23.02 Billion ≈ $3.37 Billion |
CN¥5.34 Billion ≈ $780.98 Million |
0.232x | +25.09% |
| 2022-12-31 | CN¥16.87 Billion ≈ $2.47 Billion |
CN¥3.13 Billion ≈ $457.65 Million |
0.185x | -8.00% |
| 2021-12-31 | CN¥14.13 Billion ≈ $2.07 Billion |
CN¥2.85 Billion ≈ $416.62 Million |
0.202x | +27.14% |
| 2020-12-31 | CN¥14.00 Billion ≈ $2.05 Billion |
CN¥2.22 Billion ≈ $324.77 Million |
0.158x | -0.58% |
| 2019-12-31 | CN¥13.91 Billion ≈ $2.03 Billion |
CN¥2.22 Billion ≈ $324.38 Million |
0.159x | -30.12% |
| 2018-12-31 | CN¥12.95 Billion ≈ $1.89 Billion |
CN¥2.95 Billion ≈ $432.19 Million |
0.228x | +127.17% |
| 2017-12-31 | CN¥11.98 Billion ≈ $1.75 Billion |
CN¥1.20 Billion ≈ $176.06 Million |
0.100x | -33.27% |
| 2016-12-31 | CN¥11.47 Billion ≈ $1.68 Billion |
CN¥1.73 Billion ≈ $252.48 Million |
0.150x | +35.54% |
| 2015-12-31 | CN¥11.16 Billion ≈ $1.63 Billion |
CN¥1.24 Billion ≈ $181.37 Million |
0.111x | -0.06% |
| 2014-12-31 | CN¥10.97 Billion ≈ $1.61 Billion |
CN¥1.22 Billion ≈ $178.34 Million |
0.111x | +6.02% |
| 2013-12-31 | CN¥10.02 Billion ≈ $1.47 Billion |
CN¥1.05 Billion ≈ $153.70 Million |
0.105x | +135.82% |
| 2012-12-31 | CN¥9.06 Billion ≈ $1.33 Billion |
CN¥402.77 Million ≈ $58.94 Million |
0.044x | +2.77% |
| 2011-12-31 | CN¥7.93 Billion ≈ $1.16 Billion |
CN¥342.93 Million ≈ $50.18 Million |
0.043x | +104.24% |
| 2010-12-31 | CN¥7.05 Billion ≈ $1.03 Billion |
CN¥149.29 Million ≈ $21.85 Million |
0.021x | -86.66% |
| 2009-12-31 | CN¥1.58 Billion ≈ $231.12 Million |
CN¥250.69 Million ≈ $36.68 Million |
0.159x | -14.55% |
| 2008-12-31 | CN¥1.19 Billion ≈ $174.17 Million |
CN¥221.08 Million ≈ $32.35 Million |
0.186x | -23.77% |
| 2007-12-31 | CN¥691.22 Million ≈ $101.15 Million |
CN¥168.42 Million ≈ $24.65 Million |
0.244x | -- |
About Sichuan Kelun Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more